At the Longevity Summit Dublin 2024, Peter Diamandis, founder of the XPRIZE Foundation, discussed his commitment to advancing longevity science. He shared his vision for the future, where breakthroughs in reversing ageing could lead to significant extensions of human healthspan. Diamandis outlined the XPRIZE’s role in driving innovation by offering financial incentives to teams working on age-reversal technologies. His talk reflected optimism about the convergence of AI, biotechnology, and human longevity.

Key Points:

• Origins of Interest in Longevity: Peter Diamandis traced his passion for longevity back to medical school, where he questioned why the human lifespan is limited compared to long-living species such as whales and Greenland sharks. His drive to extend his own lifespan was also motivated by his desire to see advancements in space exploration.
• XPRIZE Foundation and Longevity: Diamandis spoke about the role of the XPRIZE Foundation in incentivizing innovation. The XPRIZE Healthspan was launched with a prize pool of $11 million to encourage breakthroughs in reversing age-related functional decline.
• Longevity Escape Velocity: Diamandis believes that we are on the cusp of a technological revolution in ageing science. He emphasized that this decade could be when we unlock the tools to significantly extend human healthspan and lifespan.
• Measurable Reversal of Ageing: The XPRIZE focuses on measuring the reversal of functional loss related to ageing, specifically targeting cognitive function, muscle strength, and the immune system. Diamandis emphasized the importance of measurable results in ageng interventions.
• AI and Longevity: He highlighted the potential of artificial intelligence (AI) as a key tool in advancing longevity research, noting that the combination of AI and biotechnology could accelerate progress.
• Future Vision and Longevity Business: Diamandis sees longevity as the largest business opportunity of the future, alongside AI. He encouraged investors and innovators to seize the opportunity to impact global health and human life extension.